AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
TELMISARTAN + AMLODIPINE
31 registrations across 7 African markets— 23 active
Markets with TELMISARTAN + AMLODIPINE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| TWYNSTA 80/10MG TABLETS (Each tablet contains Telmisartan/Amlodipine 80mg/10mg) | 🇬🇭Ghana | — | active | Jan 2031 |
| TWYNSTA 80/5MG TABLETS (Each tablet contains Telmisartan/Amlodipine 80mg/5mg) | 🇬🇭Ghana | — | active | Jan 2031 |
| TWYNSTA 80/5MG TABLETS (Each tablet contains Telmisartan/Amlodipine 80mg/5mg) | 🇬🇭Ghana | — | active | Jan 2031 |
| TWYNSTA 80/10MG TABLETS (Each tablet contains Telmisartan/Amlodipine 80mg/10mg) | 🇬🇭Ghana | — | active | Jan 2031 |
| Embateltan A40 Plus Tablet_ Tablet | 🇳🇬Nigeria | Embassy Pharmaceutical and Chemicals Limited | active | Oct 2030 |
| Embateltan A80 Plus Tablet_ Tablet | 🇳🇬Nigeria | Embassy Pharmaceutical and Chemicals Limited | active | Oct 2030 |
| Cilzec-A 40+10 Tablets_ Tablet | 🇳🇬Nigeria | Mega Lifesciences Nigeria Limited | active | Sept 2030 |
| Cilzec-A 80+5 Tablets_ Tablet | 🇳🇬Nigeria | Mega Lifesciences Nigeria Limited | active | Sept 2030 |
| Cilzec-A 80+10 Tablets_ Tablet | 🇳🇬Nigeria | Mega Lifesciences Nigeria Limited | active | Sept 2030 |
| Cilzec-A 40+5 Tablets_ Tablet | 🇳🇬Nigeria | Mega Lifesciences Nigeria Limited | active | Sept 2030 |
| Amlotel 80/10 Tablets Tablet Uncoated | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | Jul 2029 |
| Amlotel 80/5 Tablets Tablet Uncoated | 🇿🇲Zambia | Innovata Pharmaceuticals (Pty) Ltd | active | May 2029 |
| TESAMOLOT 80/5 | 🇿🇦South Africa | Dr ReddyÆs Laboratories (Pty) Ltd | active | Feb 2028 |
| TESAMOLOT 40/10 | 🇿🇦South Africa | Dr ReddyÆs Laboratories (Pty) Ltd | active | Feb 2028 |
| TESAMOLOT 80/10 | 🇿🇦South Africa | Dr ReddyÆs Laboratories (Pty) Ltd | active | Feb 2028 |
| TELMYCOR-AM Comprimé / 40 mg/10 mg | 🇹🇳Tunisia | THERA | expired | Mar 2023 |
| TELMYCOR-AM Comprimé / 80 mg/5 mg | 🇹🇳Tunisia | THERA | expired | Mar 2023 |
| TELMYCOR-AM Comprimé / 40 mg/5 mg | 🇹🇳Tunisia | THERA | expired | Mar 2023 |
| TELMYCOR-AM Comprimé / 80 mg/10 mg | 🇹🇳Tunisia | THERA | expired | Mar 2023 |
| TWYNSTA Comprimé / 80 mg/5 mg | 🇹🇳Tunisia | BOEHRINGER ING.INT.GmbH | expired | Jan 2017 |
| TWYNSTA Comprimé / 80 mg/10 mg | 🇹🇳Tunisia | BOEHRINGER ING.INT.GmbH | expired | Jan 2017 |
| TWYNSTA Comprimé / 40 mg/10 mg | 🇹🇳Tunisia | BOEHRINGER ING.INT.GmbH | expired | Oct 2016 |
| TWYNSTA Comprimé / 40 mg/5 mg | 🇹🇳Tunisia | BOEHRINGER ING.INT.GmbH | expired | Oct 2016 |
| TELMIS-A comprimé / 40 mg /10 mg | 🇸🇳Senegal | GENIX | active | — |
| TELMIS-A comprimé / 40 mg /10 mg | 🇸🇳Senegal | GENIX | active | — |
| ARBITEL-AM CP PELL BTE (3 X 10) MICRO LABS LTD comprimé pelliculé, boîte de 3 | 🇲🇬Madagascar | MICRO LABS LTD (No. 31) | active | — |
| TELE-AM CP BTE (10X10) SUNRISE INTERNATIONAL LABS LTD. comprimé, boîte de 10 blisters | 🇲🇬Madagascar | SUNRISE INTERNATIONAL LABS | active | — |
| TELMIKAA AM 40MG/5MG CP BICOUCHE BTE(3 X 10) TROIKAA Comprimé bicouche, boîte de | 🇲🇬Madagascar | TROIKAA PHARMACEUTICALS | active | — |
| TELE-AM CP BTE (10X10) SUNRISE INTERNATIONAL LABS LTD. comprimé, boîte de 10 blisters | 🇲🇬Madagascar | SUNRISE INTERNATIONAL LABS | active | — |
| TELMIKAA AM 40MG/5MG CP BICOUCHE BTE(3 X 10) TROIKAA Comprimé bicouche, boîte de | 🇲🇬Madagascar | TROIKAA PHARMACEUTICALS | active | — |
| ARBITEL-AM CP PELL BTE (3 X 10) MICRO LABS LTD comprimé pelliculé, boîte de 3 | 🇲🇬Madagascar | MICRO LABS LTD (No. 31) | active | — |
TELMISARTAN + AMLODIPINE in Africa — Regulatory Overview
TELMISARTAN + AMLODIPINE is registered across 7 African markets with 31 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Madagascar, Nigeria, Ghana and 3 more. AfricaRegulatory refreshes this data daily from official government sources.
Of the 31 registrations, 23 (74%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.